Apimeds Pharmaceuticals US, Inc. (APUS)
Data as of , from SEC Form 4 filings.
See up to 3 months of APUS. The 7-day demo opens the 1M and 3M ranges and puts APUS on your watchlist.
Start 7-day demoLatest APUS insider trades
About Apimeds Pharmaceuticals US, Inc. (APUS)
Apimeds Pharmaceuticals US, Inc. files with the SEC under CIK 0001894525 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
APUS Form 4 activity by transaction type, last 90 days
No Form 4 activity for APUS in the last 90 days.
APUS insider transactions (Form 4)
1212 Form 4 filings on record, the earliest from Oct 15, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jakap Koo - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Hankil Yoon - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Bennett Weintraub - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Elona Kogan - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Carol A. O'Donnell - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Elona Kogan - Director | Grant or award | Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Carol A. O'Donnell - Director | Grant or award | Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Jakap Koo - Director | Grant or award | Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Hankil Yoon - Director | Grant or award | Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Bennett Weintraub - Director | Grant or award | Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Christopher Kim - Officer | Grant or award | Stock Option (right to buy) | 3,000 | $0.00 | - | |
| Erik C. Emerson - Officer | Grant or award | Stock Option (right to buy) | 215,000 | $0.00 | - |
APUS insider trading FAQ
What is the latest insider trade for APUS?
Apimeds Pharmaceuticals US, Inc. (APUS) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-11-13. The full record for APUS runs to 12 Form 4 filings, the earliest from 2025-10-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying APUS stock?
No insider purchases of APUS were filed in the last 90 days.
How many insiders are selling APUS stock?
No insider sales of APUS were filed in the last 90 days.
Where can I see APUS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects APUS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jakap Koo view on EDGAR
- - Hankil Yoon view on EDGAR
- - Bennett Weintraub view on EDGAR
- - Elona Kogan view on EDGAR
- - Carol A. O'Donnell view on EDGAR
- - Elona Kogan view on EDGAR
- - Carol A. O'Donnell view on EDGAR
- - Jakap Koo view on EDGAR
- - Hankil Yoon view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where APUS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow APUS with a 7-day demo
- APUS on your watchlist
- Every APUS Form 4 filing on record
- Up to 3 months of APUS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
